Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Tavaborole Topical Solution, 5% (USRLD: Kerydin Topical Solution).
Taro Pharma`s Generic Tavaborole Receives Approval In US
Drug firm Lupin Limited (Lupin) today announced that it has received approval for its Tavaborole Topical Solution, 5%, from the United States Food and Drug Administration, to market a generic equivalent of Kerydin Topical Solution, 5%, of Anacor Pharmaceuticals, Inc.
Flatwing`s Tavaborole Receives Approval In US
Aleor Dermaceuticals Generic Tavaborole Receives Approval in US
Amneal`s Generic Tavaborole Receives Approval In US
Aleor Dermaceuticals Generic Tavaborole Receives Approval in US
Encube`s Generic Clobetasol Propionate Approval in US
Aleor Dermaceuticals Generic Tavaborole Receives Tentative Approval in US
Encube Ethicals`s Generic Tavaborole Receives Tentative Approval in US